Simplex Trading
IMCR icon

Simplex Trading’s Immunocore IMCR Stock Holding History

Simplex Trading’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,451
Closed -$42.9K – 9741
2026
Q1 		$43.7K Buy
+1,451
New +$46.9K ﹤0.01% 6025
2025
Q3 		– Sell
-54
Closed -$1.83K – 9483
2025
Q2 		$1K Buy
+54
New +$1.68K ﹤0.01% 8334
2025
Q1 		– Sell
-1,350
Closed -$40.5K – 9005
2024
Q4 		$39K Buy
1,350
+479
+55% +$15.1K ﹤0.01% 6117
2024
Q3 		$27K Buy
+871
New +$31.7K ﹤0.01% 6439
2023
Q4 		– Sell
-1,793
Closed -$93.2K – 9283
2023
Q3 		$93K Buy
+1,793
New +$106K ﹤0.01% 5162
2023
Q2 		– Sell
-1,394
Closed -$79.6K – 9412
2023
Q1 		$68K Buy
+1,394
New +$78.4K ﹤0.01% 5577
2022
Q4 		– Sell
-472
Closed -$26.6K – 9726
2022
Q3 		$22K Sell
472
-28
-6% -$1.33K ﹤0.01% 7411
2022
Q2 		$18K Sell
500
-186
-27% -$6.04K ﹤0.01% 7717
2022
Q1 		$20K Buy
+686
New +$17.3K ﹤0.01% 8255

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Simplex Trading's IMCR Position: Q2 2026 in Review

Simplex Trading sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 1,451 shares — an estimated $42.9K sold.

Simplex Trading first reported a position in IMCR in Q1 2022 and held it in 9 quarters. The position peaked at $93K in Q3 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Simplex Trading reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 1,451 Immunocore shares in Q2 2026, an estimated $42.9K.
  • Simplex Trading first reported a position in Immunocore in Q1 2022 and held it in 9 quarters.
  • Simplex Trading's Immunocore position peaked at $93K in Q3 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.